Armistice Capital »

Bioaffinity Technologies shares owned by Armistice Capital

Quarter-by-quarter ownership of Bioaffinity Technologies (BIAFW) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Bioaffinity Technologies

Tip: Access up to 7 years of quarterly data

All positions including Bioaffinity Technologies held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioaffinity Technologies by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $61k 204k 0.30
2024-03-31 $156k 204k 0.77
2023-09-30 $19k 204k 0.09
2023-06-30 $105k 204k 0.51
2023-03-31 $61k 204k 0.30
2022-12-31 $86k 204k 0.42
2022-09-30 $72k 204k 0.35

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Immunovant (IMVT)
Agios Pharmaceuticals (AGIO)
Argenx Se Sponsored Adr (ARGX)
Novo-nordisk A S Adr (NVO)
Sanofi Sponsored Adr (SNY)
Alkermes SHS (ALKS)
Medtronic SHS (MDT)
Aurinia Pharmaceuticals (AUPH)

View all positions for Armistice Capital

Top funds holding Bioaffinity Technologies

Armistice Capital
Clear Street
Citadel Advisors

View all funds holding Bioaffinity Technologies